THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
152,335,132
Share change
-30,575,536
Total reported value
$190,408,846
Put/Call ratio
182%
Price per share
$1.25
Number of holders
142
Value change
-$36,023,732
Number of buys
68
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q2 2020

As of 30 Jun 2020, THERAPEUTICSMD INC - COM (TXMD) was held by 142 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 152,335,132 shares. The largest 10 holders included BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, JPMORGAN CHASE & CO, VANGUARD GROUP INC, Rubric Capital Management LP, C WorldWide Group Holding A/S, GMT CAPITAL CORP, AMERIPRISE FINANCIAL INC, and STATE STREET CORP. This page lists 142 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.